Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients

Karatas F., Erdem G. U., Sahin S., Aytekin A., YÜCE D., SEVER A. R., ...Daha Fazla

BREAST, cilt.32, ss.237-244, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1016/j.breast.2016.05.013
  • Dergi Adı: BREAST
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.237-244
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Purpose: The relation between higher body mass index (BMI) and pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in breast cancer (BC) is a controversial issue according to the data of Western and Asian patients. The aim of this study is to evaluate BMI and pCR to NAC and discuss the importance of pCR outcomes in Turkish BC patients as a bridging country between Europe and Asia.